- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/30 - IndolesHydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/30
Total number of patents in this class: 321
10-year publication summary
|
13
|
21
|
18
|
23
|
16
|
14
|
28
|
17
|
22
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 155 |
10 |
| Cornell University | 3441 |
8 |
| Novita Pharmaceuticals, Inc. | 24 |
8 |
| UCB Pharma GmbH | 79 |
8 |
| LG Chem, Ltd. | 17950 |
7 |
| Bristol-myers Squibb Company | 4757 |
5 |
| Suven Life Sciences Limited | 138 |
5 |
| Radius Pharmaceuticals, Inc. | 56 |
5 |
| Triana Biomedicines, Inc. | 24 |
5 |
| Vertex Pharmaceuticals Incorporated | 1579 |
4 |
| CFD Research Corporation | 58 |
4 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
4 |
| Vanderbilt University | 2028 |
4 |
| Centre National de La Recherche Scientifique | 11059 |
3 |
| Bayer Cropscience AG | 1836 |
3 |
| FUJIFILM Corporation | 30594 |
3 |
| Amira Pharmaceuticals, Inc. | 66 |
3 |
| The Board of Regents of the University of Oklahoma | 657 |
3 |
| Ono Pharmaceutical Co., Ltd. | 422 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
3 |
| Other owners | 223 |